Age (yrs) | Burkina Faso | Senegal | Ghana* | Niger* | Mean†for Sp | Mean†for Nm‡
|
---|
<1 | 77 | 95 | 42 | 150 | 98 | 24 |
1 to 4 | 14 | 17 | 19 | 10 | 14 | 20 |
5 to 9 | 13 | 4.5 | 25 | 6.4 | 9.1 | 19 |
10 to 14 | 10 | 3.7 | Â | 6.9 | 7.8 | 17 |
15 to 19 | 11 | 2.4 | 20 | 9 | 7.8 | 11 |
20 to 29 | 6.1 | 4.0 | Â | 4.7 | 5.8 | 5.0 |
30 to 39 | 14.1 | 5.2 | 18 | 3.2 | 8.6 | 3.3 |
40 to 49 | 19.1 | 7.8 | Â | 7.9 | 12 | 2.8 |
50 to 59 | 8.0 | 11 | Â | Â | 9.7 | 3.3 |
60+ | 8.1 | 15 | 25 | Â | 10 | 2.8 |
- *Not all studies reported age groups at the detail shown in column 1. The incidences in Ghana for persons age 5 to 19, 15 to 29, and 30 to 59 years and in Niger for persons 40+ years were 25, 20, 18, and 7.9 per 100,000 persons per year, respectively.
-
†Weighted mean based on population under surveillance. Where data were not available from a study site for a specific age group, the next oldest age group was used in the calculation of the weighted mean.
-
‡ Nm = Neisseria meningitidis. For comparison, data on Nm are presented for the same surveillance periods and sites except for Ghana, which did not report these data.